[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"case:isa-pharmaceuticals-bv-34215632:header:guest:personal:":3,"case:isa-pharmaceuticals-bv-34215632:documents:guest:personal::{}":74,"case:isa-pharmaceuticals-bv-34215632:document-search:":188},{"id":4,"slug":5,"name":6,"trade_names":7,"status":8,"procedure":9,"procedure_type":10,"insolvency_number":29,"case_number":29,"declared_on":30,"terminated_on":14,"termination_reason":14,"kvk_number":31,"legal_form":32,"sbi":14,"court":35,"judge":38,"judge_source":39,"curator":40,"location":46,"counts":52,"pages":56,"follower_count":55,"report_count":53,"last_report_on":68,"last_update_at":69,"freshness":70,"linked":73},"01M4M089BXHD3N5A7FB3ZWRDS7","isa-pharmaceuticals-bv-34215632","ISA Pharmaceuticals B.V.",[],"active","bankruptcy",{"id":11,"key":9,"family":12,"name":13,"short_name":14,"legal_basis":15,"features":19},"01M3Y8CPCPT53NPXHK39BWK1QY","insolvency","Faillissement",null,{"name":16,"provision":17,"url":18},"Faillissementswet","Titel I (art. 1 e.v.)","https:\u002F\u002Fwetten.overheid.nl\u002FBWBR0001860",[20,21,22,23,24,25,26,27,28],"reports","financials","creditors","assets","investigations","curator_workspace","appointments","court_decisions","portfolio_monitoring","F.13\u002F24\u002F308","2024-07-18","34215632",{"value":33,"source":34},"BV","cir",{"name":36,"slug":37,"location":14},"Rechtbank Amsterdam","amsterdam","mr. W.M. de Vries",{"type":34,"report_number":14,"published_on":14},{"name":41,"slug":42,"law_firm":43,"city":44,"verified":45},"mr. B.F. van Noort","bf-van-noort","Van Diepen Van der Kroef Advocaten","Amsterdam",false,{"street":47,"house_number":48,"addition":14,"postal_code":49,"city":50,"municipality":14,"province":14,"lat":14,"lng":14,"kind":51,"source":34},"De Limes","7","2342DH","Oegstgeest","business",{"reports":53,"documents":54,"assets":53,"investigations":55,"news":55},9,20,0,{"overview":57,"reports":59,"financials":60,"investigations":61,"assets":62,"timeline":63,"documents":64,"news":65,"company":66,"compare":67},{"index":58,"ads":45},true,{"index":58,"ads":45},{"index":58,"ads":45},{"index":45,"ads":45},{"index":58,"ads":45},{"index":58,"ads":45},{"index":58,"ads":45},{"index":45,"ads":45},{"index":58,"ads":45},{"index":45,"ads":45},"2026-08-19","2026-10-10T22:52:31+00:00",{"last_checked_at":71,"last_reconciled_at":71,"stale":45,"status":72},"2026-10-10T22:52:02+00:00","current",{"continued_from":14,"continued_as":14},{"data":75},[76,84,88,97,103,107,113,117,124,128,134,138,145,149,156,160,166,171,176,181],{"kind":77,"id":78,"title":79,"report_number":53,"report_date":68,"date":68,"pages":80,"category":81,"source":82,"url":83,"searchable":58},"report","01M4M095GWFFVJD87FWP6B9CR5","Verslag:  19-08-2026",24,"official","rechtspraak","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M095GWFFVJD87FWP6B9CR5.pdf",{"kind":77,"id":85,"title":86,"report_number":53,"report_date":68,"date":68,"pages":53,"category":81,"source":82,"url":87,"searchable":58},"01M4M093WEF601FA8VF2GBNQ5Z","Financieel verslag  19-08-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M093WEF601FA8VF2GBNQ5Z.pdf",{"kind":89,"id":90,"title":91,"report_number":14,"date":92,"pages":93,"category":81,"source":34,"url":14,"searchable":45,"publication_type":94,"publication_number":95,"stored_at":71,"download_url":96},"publication","01M4M089EZVH9DF977HD96KN48","Vervanging rechter-commissaris mr. C.H. Rombouts door mr. W.M. de Vries.","2026-07-03",1,"other","13.ams.24.308.F.1328.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Fisa-pharmaceuticals-bv-34215632\u002Fpublications\u002F01M4M089EZVH9DF977HD96KN48\u002Fdownload",{"kind":77,"id":98,"title":99,"report_number":100,"report_date":101,"date":101,"pages":53,"category":81,"source":82,"url":102,"searchable":58},"01M4M092NJHGQNHWE4VM1H5W6B","Financieel verslag  19-05-2026",8,"2026-05-19","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M092NJHGQNHWE4VM1H5W6B.pdf",{"kind":77,"id":104,"title":105,"report_number":100,"report_date":101,"date":101,"pages":80,"category":81,"source":82,"url":106,"searchable":58},"01M4M091BQ1611212W2FHQTKCN","Verslag:  19-05-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M091BQ1611212W2FHQTKCN.pdf",{"kind":77,"id":108,"title":109,"report_number":110,"report_date":111,"date":111,"pages":53,"category":81,"source":82,"url":112,"searchable":58},"01M4M08X2JFHDDE7VDCSZR4QWN","Financieel verslag 19-02-2026",7,"2026-02-19","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08X2JFHDDE7VDCSZR4QWN.pdf",{"kind":77,"id":114,"title":115,"report_number":110,"report_date":111,"date":111,"pages":80,"category":81,"source":82,"url":116,"searchable":58},"01M4M08ZM6JKVZ37QFPTG14GF3","Verslag: 19-02-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08ZM6JKVZ37QFPTG14GF3.pdf",{"kind":77,"id":118,"title":119,"report_number":120,"report_date":121,"date":121,"pages":122,"category":81,"source":82,"url":123,"searchable":58},"01M4M08T1DFK1VWAT8VRCJVZ2N","Verslag: 19-11-2025",6,"2025-11-19",21,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08T1DFK1VWAT8VRCJVZ2N.pdf",{"kind":77,"id":125,"title":126,"report_number":120,"report_date":121,"date":121,"pages":53,"category":81,"source":82,"url":127,"searchable":58},"01M4M08V8232JK7WR71JZRHWW0","Financieel verslag 19-11-2025","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08V8232JK7WR71JZRHWW0.pdf",{"kind":77,"id":129,"title":130,"report_number":131,"report_date":132,"date":132,"pages":53,"category":81,"source":82,"url":133,"searchable":58},"01M4M08PX39SKEQM0315DD41P7","Financieel verslag 19-08-2025",5,"2025-08-19","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08PX39SKEQM0315DD41P7.pdf",{"kind":77,"id":135,"title":136,"report_number":131,"report_date":132,"date":132,"pages":54,"category":81,"source":82,"url":137,"searchable":58},"01M4M08RD51WEERT9ZD62BS3BZ","Verslag: 19-08-2025","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08RD51WEERT9ZD62BS3BZ.pdf",{"kind":77,"id":139,"title":140,"report_number":141,"report_date":142,"date":142,"pages":143,"category":81,"source":82,"url":144,"searchable":58},"01M4M08M82MPYMAR3067ZFHTR1","Verslag: 19-05-2025",4,"2025-05-19",18,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08M82MPYMAR3067ZFHTR1.pdf",{"kind":77,"id":146,"title":147,"report_number":141,"report_date":142,"date":142,"pages":53,"category":81,"source":82,"url":148,"searchable":58},"01M4M08NKE81YFVMKJDAM2ZN58","Financieel verslag 19-05-2025","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08NKE81YFVMKJDAM2ZN58.pdf",{"kind":77,"id":150,"title":151,"report_number":152,"report_date":153,"date":153,"pages":154,"category":81,"source":82,"url":155,"searchable":58},"01M4M08JR1TWPW667JCKQ03VS2","Verslag: 19-02-2025",3,"2025-02-19",17,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08JR1TWPW667JCKQ03VS2.pdf",{"kind":77,"id":157,"title":158,"report_number":152,"report_date":153,"date":153,"pages":53,"category":81,"source":82,"url":159,"searchable":58},"01M4M08H1GZJ0AVJ1EAPQMVJBA","Financieel verslag 19-02-2025","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08H1GZJ0AVJ1EAPQMVJBA.pdf",{"kind":77,"id":161,"title":162,"report_number":163,"report_date":164,"date":164,"pages":53,"category":81,"source":82,"url":165,"searchable":58},"01M4M08FV4J8EBPE54FFFQSDK6","Financieel verslag 19-11-2024",2,"2024-11-19","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08FV4J8EBPE54FFFQSDK6.pdf",{"kind":77,"id":167,"title":168,"report_number":163,"report_date":164,"date":164,"pages":169,"category":81,"source":82,"url":170,"searchable":58},"01M4M08E79P9CQ5N1WM14C9ZG4","Verslag: 19-11-2024",14,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08E79P9CQ5N1WM14C9ZG4.pdf",{"kind":77,"id":172,"title":173,"report_number":93,"report_date":174,"date":174,"pages":100,"category":81,"source":82,"url":175,"searchable":58},"01M4M08BFKJN6ZCBGHW3QQ07BE","Financieel verslag 19-08-2024","2024-08-19","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08BFKJN6ZCBGHW3QQ07BE.pdf",{"kind":77,"id":177,"title":178,"report_number":93,"report_date":174,"date":174,"pages":179,"category":81,"source":82,"url":180,"searchable":58},"01M4M08CV3WWAN0ND90FAEAT2F","Verslag: 19-08-2024",12,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M08CV3WWAN0ND90FAEAT2F.pdf",{"kind":89,"id":182,"title":183,"report_number":14,"date":184,"pages":93,"category":81,"source":34,"url":14,"searchable":45,"publication_type":185,"publication_number":186,"stored_at":71,"download_url":187},"01M4M089DSE5KWZ54PR58A4C41","Uitspraak faillissement na beëindiging surseance op 18 juli 2024","2024-07-19","declaration","13.ams.24.308.F.1306.1.24","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Fisa-pharmaceuticals-bv-34215632\u002Fpublications\u002F01M4M089DSE5KWZ54PR58A4C41\u002Fdownload",[]]